Showing results (161-170 of 432) with videos related to
Sort By:
Pageof 44
Bioorganic & Medicinal Chemistry|December 8, 2004
Synthesis and receptor assay of aromatic-ethynyl-aromatic derivatives with potent mGluR5 antagonist activityDavid Alagille, Ronald M Baldwin, Bryan L Roth, et al.Beilstein Journal of Organic Chemistry|December 5, 2012
trans-2-(2,5-Dimethoxy-4-iodophenyl)cyclopropylamine and trans-2-(2,5-dimethoxy-4-bromophenyl)cyclopropylamine as potent agonists for the 5-HT(2) receptor familyAdam Pigott, Stewart Frescas, John D McCorvy, et al.Bioorganic & Medicinal Chemistry Letters|August 3, 2005
SAR of psilocybin analogs: discovery of a selective 5-HT 2C agonistHoward Sard, Govindaraj Kumaran, Cynthia Morency, et al.Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Functionalization at position 3 of the phenyl ring of the potent mGluR5 noncompetitive antagonists MPEPDavid Alagille, Ronald M Baldwin, Bryan L Roth, et al.The Journal of Biological Chemistry|December 24, 2008
Ribosomal S6 kinase 2 directly phosphorylates the 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor, thereby modulating 5-HT2A signalingRyan T Strachan, Douglas J Sheffler, Belinda Willard, et al.Psychopharmacology|March 15, 2005
The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?Marilyn A Davies, Beth Ann Compton-Toth, Sandra J Hufeisen, et al.Assay and Drug Development Technologies|March 21, 2012
An automated electrophysiological assay for differentiating Ca(v)2.2 inhibitors based on state dependence and kineticsAndrew M Swensen, Wende Niforatos, Timothy A Vortherms, et al.Journal of Medicinal Chemistry|July 22, 2017
A Simple Representation of Three-Dimensional Molecular StructureSeth D Axen, Xi-Ping Huang, Elena L Cáceres, et al.Bioorganic & Medicinal Chemistry|January 17, 2012
Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agentsKwakye Peprah, Xue Y Zhu, Suresh V K Eyunni, et al.Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Evaluation of the eutomer of 4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one, {(+)-SYA 09}, a pyrrolidine analog of haloperidolSeth Y Ablordeppey, Margaret Lyles-Eggleston, Barbara Bricker, et al.Pageof 44